Biohaven annual total liabilities
2021
2022
2023
2024
2025
Biohaven Total Liabilities Growth & History (BHVN)
Biohaven's total liabilities was $399.4M for fiscal 2025.
View full Biohaven company overviewBiohaven annual total liabilities history
| Fiscal year | Period ended | Total liabilities | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $399.4M | $207.7M | +108.36% |
| 2024 | 2024-12-31 | $191.7M | $106.4M | +124.87% |
| 2023 | 2023-12-31 | $85.2M | −$37.8M | −30.71% |
| 2022 | 2022-12-31 | $123.0M | $75.6M | +159.68% |
| 2021 | 2021-12-31 | $47.4M | — | — |
Biohaven quarterly total liabilities
Q4.21
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total liabilities | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $358.5M | −$57.3M | −13.78% |
| Q1 2026 | 2026-03-31 | $336.9M | $137.5M | +68.92% |
| Q4 2025 | 2025-12-31 | $399.4M | $207.7M | +108.36% |
| Q3 2025 | 2025-09-30 | $426.3M | $231.8M | +119.15% |
| Q2 2025 | 2025-06-30 | $415.8M | $216.9M | +109.06% |
| Q1 2025 | 2025-03-31 | $199.5M | $82.4M | +70.35% |
| Q4 2024 | 2024-12-31 | $191.7M | $106.4M | +124.87% |
| Q3 2024 | 2024-09-30 | $194.5M | $101.8M | +109.77% |
| Q2 2024 | 2024-06-30 | $198.9M | $79.4M | +66.47% |
| Q1 2024 | 2024-03-31 | $117.1M | −$29.2M | −19.95% |
| Q4 2023 | 2023-12-31 | $85.2M | −$37.8M | −30.71% |
| Q3 2023 | 2023-09-30 | $92.7M | $57.3M | +161.73% |
| Q2 2023 | 2023-06-30 | $119.5M | — | — |
| Q1 2023 | 2023-03-31 | $146.3M | — | — |
| Q4 2022 | 2022-12-31 | $123.0M | $75.6M | +159.68% |
| Q3 2022 | 2022-09-30 | $35.4M | — | — |
| Q4 2021 | 2021-12-31 | $47.4M | — | — |
Biohaven total liabilities trends
Between the periods ended 2021-12-31 and 2025-12-31, Biohaven's total liabilities increased from $47.4M to $399.4M, a change of $352.0M. The latest reported quarter, Q2 2026, shows $358.5M.
About the metric
What total liabilities mean
Total liabilities are all obligations reported on a company’s balance sheet, including debt, accounts payable, accrued expenses, deferred revenue, lease liabilities, and other current and long-term obligations.
Calculation and source
SEC-reported and calculated total liabilities
TickerStat uses total liabilities reported in company SEC filings when available. Otherwise, it calculates total liabilities as aligned total assets minus total equity for the same balance-sheet date. Total liabilities should not be confused with interest-bearing debt. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biohaven source filings ↗Community posts
FDA accepts Biohaven's resubmitted application for spinocerebellar ataxia drug
Biohaven ($BHVN) said the FDA accepted its resubmitted application for Vyglxia, the proposed brand for troriluzole, to treat spinocerebellar ataxia. The submission includes additional supportive analyses and was deemed a complete response t ...
